Disclaimer This article is for educational purposes only and does not constitute legal advice
The study authors concluded that reactive hypoglycemia in dumping syndrome following bariatric surgery is caused by increased GLP-1 concentration potentiating insulin release ( Another similar study measured plasma incretin, insulin, and glucose concentration in gastrectomy patients compared to controls
Vomiting occurred in 5% and 9.2% versus 2.3%
Not approved by any regulatory authority as of June 2026
Manufacturer Assistance Programs : Pharmaceutical companies such as Novo Nordisk and Eli Lilly offer patient assistance programs (PAPs) that can significantly reduce or even eliminate the cost of GLP-1 medications for eligible patients
These benefits were further supported by the results of the SUMMIT trial, which investigated tirzepatide, a dual GLP-1/glucose-dependent insulinotropic polypeptide receptor agonist, in patients with HFpEF with or without T2D
